Department of Ophthalmology, Scientific Institute San Raffaele, Milan, Italy.
Retina. 2011 Jul-Aug;31(7):1352-8. doi: 10.1097/IAE.0b013e318203c0aa.
To identify by noninvasive means early retinal abnormalities that may predict diabetic macular edema.
The authors analyzed retrospectively data from consecutive patients with Type 1 (n = 16) or Type 2 (n = 23) diabetes who presented for routine follow-up of early retinopathy, had no clinical signs or symptoms of diabetic macular edema, and were evaluated with spectral-domain optical coherence tomography. Age- and gender-matched nondiabetic subjects provided normative data.
Spectral-domain optical coherence tomography revealed in the macular region of diabetic patients small hyporeflective areas (median diameter, 55 μm) contained within discrete retinal layers that we named micropseudocysts (MPCs). Micropseudocysts are associated with vascular leakage. The patients showing MPCs had more frequently systemic hypertension and increased central foveal thickness than those without MPCs. The association with increased central foveal thickness was only in the patients with Type 2 diabetes.
Macular MPCs in patients with mild diabetic retinopathy appear to reflect leakage and can precede macular thickening. The association of MPCs with increased central foveal thickness in patients with Type 2 diabetes, but not in patients with Type 1 diabetes, points to a greater tendency to retinal fluid accumulation in patients with Type 2 diabetes. Studies in larger cohorts will determine the usefulness of MPCs in strategies to abort diabetic macular edema.
通过非侵入性手段识别可能预示糖尿病性黄斑水肿的早期视网膜异常。
作者回顾性分析了连续 16 例 1 型糖尿病和 23 例 2 型糖尿病患者的数据,这些患者因早期视网膜病变的常规随访而就诊,没有糖尿病性黄斑水肿的临床症状或体征,并接受了频域光相干断层扫描检查。年龄和性别匹配的非糖尿病患者提供了正常数据。
频域光相干断层扫描在糖尿病患者的黄斑区域显示出小的低反射区域(中位数直径为 55μm),这些区域位于离散的视网膜层内,我们将其命名为微囊泡(MPC)。微囊泡与血管渗漏有关。与无 MPC 的患者相比,显示 MPC 的患者更频繁地患有系统性高血压和中央视网膜厚度增加。与中央视网膜厚度增加的关联仅见于 2 型糖尿病患者。
在轻度糖尿病性视网膜病变患者的黄斑区出现 MPC 似乎反映了渗漏,并可能先于黄斑增厚。MPC 与 2 型糖尿病患者中央视网膜厚度增加的关联,而不是 1 型糖尿病患者,表明 2 型糖尿病患者更倾向于视网膜液体积聚。在更大的队列研究中,将确定 MPC 在预防糖尿病性黄斑水肿策略中的有用性。